IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q4 2015 Holdings

Filed 2016-02-09 | 23 holdings | $22.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Accuray Inc(ARAY)COM004397105$19.5M2,884,30587.0%
Biogen Inc(BIIB)COM09062X103$2.4M7,72310.6%
Accelerate Diagnostics IncCOM004304200$121.3K5,643,5400.5%
Nxstage Medical IncCOM67072V103$72.1K3,291,0010.3%
Quidel CorpCOM74838J101$59.3K2,796,2840.3%
Pacific Biosciences Calif in(PACB)COM69404D108$48.0K3,656,4310.2%
Opko Health Inc(OPK)COM68375N103$39.3K3,913,8000.2%
Acorda Therapeutics IncCOM00484M106$34.9K815,8380.2%
Mazor Robotics LTDSPONSORED ADS57886P103$28.6K2,816,6350.1%
Tesaro IncCOM881569107$28.3K540,9660.1%
Intrexon CorpCOM46122T102$28.1K932,5850.1%
Vermillion IncCOM NEW92407M206$15.5K8,624,2250.1%
Agenus IncCOM00847G101$13.0K2,865,6530.1%
Amarin Corp PLCSPONS ADR NEW023111206$12.6K6,645,7930.1%
Webmd Health CorpCOM94770V102$11.5K238,1030.1%
Hansen MedicalCOM411307101$10.5K4,491,8200.0%
Biolase IncCOM090911108$8.9K10,529,5250.0%
Transition Therapeutics IncCOM NEW893716209$7.5K3,908,4610.0%
Chimerix Inc(CMRXEUR)COM16934W106$6.6K736,4210.0%
Contrafect Corp(CFRXEUR)COM212326102$5.6K1,182,0320.0%
Metabolix IncCOM591018809$1.4K933,6200.0%
Second Sight MED Prods IncCOM81362J100$1.2K203,4380.0%
Ziopharm Oncology IncCOM98973P101$1.1K131,5510.0%